Chemoinformaics analysis of 6,6-Dimethylbicyclo[3.1.1]heptan-2-one
Molecular Weight | 138.21 | nRot | 0 |
Heavy Atom Molecular Weight | 124.098 | nRig | 24 |
Exact Molecular Weight | 138.104 | nRing | 3 |
Solubility: LogS | -3.372 | nHRing | 0 |
Solubility: LogP | 4.363 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 24 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 9 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 25.1671 |
nHD | 0 | BPOL | 14.9129 |
QED | 0.171 |
Synth | 4.268 |
Natural Product Likeliness | 2.075 |
NR-PPAR-gamma | 0.889 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.097 |
Pgp-sub | 0.043 |
HIA | 0.17 |
CACO-2 | -6.199 |
MDCK | 0.00000731 |
BBB | 0.002 |
PPB | 0.962487 |
VDSS | 0.382 |
FU | 0.0322295 |
CYP1A2-inh | 0.043 |
CYP1A2-sub | 0.875 |
CYP2c19-inh | 0.035 |
CYP2c19-sub | 0.059 |
CYP2c9-inh | 0.619 |
CYP2c9-sub | 0.688 |
CYP2d6-inh | 0.022 |
CYP2d6-sub | 0.207 |
CYP3a4-inh | 0.099 |
CYP3a4-sub | 0.688 |
CL | 10.353 |
T12 | 0.616 |
hERG | 0.054 |
Ames | 0.086 |
ROA | 0.207 |
SkinSen | 0.958 |
Carcinogencity | 0.023 |
EI | 0.901 |
Respiratory | 0.035 |
NR-Aromatase | 0.775 |
Antiviral | No |
Prediction | 0.943122 |